Page last updated: 2024-11-04

rofecoxib and Muscle Disorders

rofecoxib has been researched along with Muscle Disorders in 1 studies

Research Excerpts

ExcerptRelevanceReference
"We assessed the effect of rofecoxib, a cyclo-oxygenase-2 inhibitor, and tramadol, a centrally acting analgesic, on both delayed-onset muscle soreness (DOMS) and experimentally induced ischaemic pain."9.11Rofecoxib and tramadol do not attenuate delayed-onset muscle soreness or ischaemic pain in human volunteers. ( Fuller, A; Loram, LC; Mitchell, D, 2005)
"We assessed the effect of rofecoxib, a cyclo-oxygenase-2 inhibitor, and tramadol, a centrally acting analgesic, on both delayed-onset muscle soreness (DOMS) and experimentally induced ischaemic pain."5.11Rofecoxib and tramadol do not attenuate delayed-onset muscle soreness or ischaemic pain in human volunteers. ( Fuller, A; Loram, LC; Mitchell, D, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Loram, LC1
Mitchell, D1
Fuller, A1

Trials

1 trial available for rofecoxib and Muscle Disorders

ArticleYear
Rofecoxib and tramadol do not attenuate delayed-onset muscle soreness or ischaemic pain in human volunteers.
    Canadian journal of physiology and pharmacology, 2005, Volume: 83, Issue:12

    Topics: Adult; Creatine Kinase; Cross-Over Studies; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Exerci

2005